Glycopeptides and b-lactams essentially block the same transpeptidation reaction, which is necessary for cross-linkage of peptidoglycanchains, but using different mechanisms: b-lactams bind, and thus, inactivate enzyme glycopeptide transpeptidase (Therrien and Levesque, 2000) whereas vancomycin binds the corresponding substrate -D-Ala-D-Ala peptide -and eliminates it from reaction (Reynolds, 1989) . Six types of glycopeptide resistance operons have been described and they are recognised by the resistance ligase (vanA,vanB, vanC, vanD, vanE and vanG) . E. faecium and E. faecalis predominantly possess VanAand VanB-type resistance. Enterococci harbouring the vanA operon display high level resistance to both vancomycin and teicoplanin whereas strains carrying the vanB operon are resistant to variable levels of vancomycin but not teicoplanin (Arthur et al., 1996) . The presence of these operons ensures a new biochemical pathway in which regular D-Ala-D-Ala peptide to which glycopeptides bind is replaced by D-Ala-D-lactate. As a result affinity between glycopeptide and a new substrate is decreased more than 1000 fold and the antibiotic becomes ineffective.
In addition to the treatment of multidrug-resistant enterococcal infections another challenge is the organism's potential to serve as a reservoir for resistance genes. In the labo-PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 63 (2009 ), No. 4/5 (663/664), pp. 234-236. DOI: 10.2478 FIRST DETECTION OF VANCOMYCIN RESISTANT Enterococcus faecium IN LATVIA Dace Rudzîte*, Arta Olga Balode** , ***, Uga Dumpis** , ****, Edvîns Miklaðeviès** , *** ratory, resistance to glycopeptide antibiotics has been transferred between enterococcal species and from enterococci to other gram-positive organisms, including streptococci, Listeria monocytogenes, and Staphylococcus. aureus (Leclercq et al., 1989; Noble et al., 1992) . Isolation of the first VRE isolates in Latvia is described in this paper.
Identification of bacterial isolates and determination of their antimicrobial resistance were performed on Vitek 2 (Biomerieux). Molecular verification of the isolate species and typing of the van operon was conducted by multiplex PCR (Depardieu et al., 2004) .
The first Latvian VRE was isolated from two patients stationed at the Rîga Eastern Clinical University Hospital in November -December (Fig. 1) .
Antimicrobial susceptibility was determined on Vitek 2 using a Gram Positive Susceptibility Card. Both strains displayed an identical resistance pattern: resistant to ampicillin, gentamicin, streptomycin, ciprofloxacin, erythromycin, clindamycin, teicoplanin (MIC32 mg/l), vancomycin (MIC256 mg/l) and trimethoprim/sulfamethoxazole, and susceptible to linezolid (MIC 2 mg/l). To investigate the mechanism responsible for the vancomycin resistance of these strains, a multiplex PCR (Depardieu et al., 2004) was used to detect the six types of glycopeptide resistance. Analyses of the amplification products revealed a band corresponding to the vanA operon in both tested isolates (Fig.  1 ). This result is in agreement with the antibiotic susceptibility test, as it is known that the vanA operon provides resistance to high levels of vancomycin and teicoplanin.
To our knowledge, this was the first outbreak of VanA-type vancomycin-resistant enterococcus in Latvia. Apparently, in the first case resistance was selected by long-term treatment with vancomycin, or acquired from another patient that remained unidentified. Later, the same strain of bacteria was transmitted to the second patient who was hospitalised in the same department at the same time. Strict infection control measures were employed later and no other secondary cases were reported later at the responsible department. In the future, routine microbiological surveillance of Enteroccocus faecium and Enterococcus faecalis resistance as infection control is recommended to early identify outbreaks of VRE. 
